Applying Sensor-Based Glucose Monitoring (CGM) to Reduce Cost-Intensive, Adverse Drug Events Associated with Diabetes Treatment

Applying Sensor-Based Glucose Monitoring (CGM) to Reduce Cost-Intensive, Adverse Drug Events Associated with Diabetes Treatment


Published

July 28, 2021

Created by

CMEducation Resources symposium

Related Presenters

Irl Hirsch, MD

Irl Hirsch, MD

Professor of Medicine
Diabetes Treatment and Teaching Chair
University of Washington Medical Center
Medical Director
UWMC Diabetes Care Center
Seattle, Washington, USA